These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37748633)

  • 41. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
    Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
    Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease.
    Athanasiadis Y; Tsatsos M; Sharma A; Hossain P
    J Ocul Pharmacol Ther; 2013; 29(6):516-22. PubMed ID: 23485045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review.
    José-Vieira R; Ferreira A; Menéres P; Sousa-Pinto B; Figueira L
    Surv Ophthalmol; 2022; 67(4):991-1013. PubMed ID: 34896190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
    Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
    J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina.
    Mizuno S; Nishiwaki A; Morita H; Miyake T; Ogura Y
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2831-6. PubMed ID: 17525219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and
    Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM
    Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of Triamcinolone Acetonide-Loaded Nanostructured Lipid Carriers (NLCs) for Buccal Drug Delivery Using the Box-Behnken Design.
    Kraisit P; Sarisuta N
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29690622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Müller cells.
    Itakura H; Akiyama H; Hagimura N; Doi H; Tanaka T; Kishi S; Kurabayashi M
    Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):226-31. PubMed ID: 16049703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
    Jonas JB; Söfker A; Degenring R
    Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye.
    Araújo J; Nikolic S; Egea MA; Souto EB; Garcia ML
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):150-7. PubMed ID: 21764568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
    Yang YH; Hsu WC; Hsieh YT
    Curr Eye Res; 2021 May; 46(5):689-693. PubMed ID: 32985270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells.
    Zhou H; Yang L; Li H; Gong H; Cheng L; Zheng H; Zhang LM; Lan Y
    Int J Nanomedicine; 2012; 7():4649-60. PubMed ID: 22942646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation.
    Xing Y; Zhu L; Zhang K; Li T; Huang S
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):308-316. PubMed ID: 33739906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Treatment of Persistent Diabetic Macular Edema with Aflibercept and Triamcinolone Acetonide in Pseudophakic Eyes.
    Petrovic N; Todorovic D; Sarenac Vulovic T; Sreckovic S; Zivic F; Risimic D
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241214
    [No Abstract]   [Full Text] [Related]  

  • 56. A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis.
    Kivitz A; Kwong L; Shlotzhauer T; Lufkin J; Cinar A; Kelley S
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19881309. PubMed ID: 31662801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
    Zeng N; Gao X; Hu Q; Song Q; Xia H; Liu Z; Gu G; Jiang M; Pang Z; Chen H; Chen J; Fang L
    Int J Nanomedicine; 2012; 7():3703-18. PubMed ID: 22888230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study.
    Navarro-Partida J; Altamirano-Vallejo JC; Lopez-Naranjo EJ; Gonzalez-De la Rosa A; Manzano-Ramírez A; Apatiga-Castro LM; Armendáriz-Borunda J; Santos A
    J Ocul Pharmacol Ther; 2020; 36(6):393-403. PubMed ID: 32564664
    [No Abstract]   [Full Text] [Related]  

  • 60. Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.
    Kim YH; Chung IY; Choi MY; Kim YS; Lee JH; Park CH; Kang SS; Roh GS; Choi WS; Yoo JM; Cho GJ
    Neurobiol Dis; 2007 Jun; 26(3):569-76. PubMed ID: 17434742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.